This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets.
New marketing authorisations
Table 1 shows the new marketing authorisations for June 2024
TABLE 1: New marketing authorisations in June 2024
| Product name and target species |
Active substance |
Authorisation, Holder, territory, and distribution category |
Therapeutic group |
| Pyrocam 20 mg/ml Solution for Injection for Cattle, Pigs and Horses |
Meloxicam |
Huvepharma NV, GB & NI, POM-V |
Anti Inflammatory NSAID |
See the VMD’s Product Information Database for more information on each of these products. There may be a delay before formal documentation is available for some Northern Ireland products, from the European Medicines Agency.
The timing of the product being placed on the market is an issue for the marketing authorisation holder.
For more information, contact the VMD at postmaster@vmd.gov.uk